Literature DB >> 24805836

Medical devices early assessment methods: systematic literature review.

Katarzyna Markiewicz1, Janine A van Til1, Maarten J IJzerman1.   

Abstract

OBJECTIVES: The aim of this study was to get an overview of current theory and practice in early assessments of medical devices, and to identify aims and uses of early assessment methods used in practice.
METHODS: A systematic literature review was conducted in September 2013, using computerized databases (PubMed, Science Direct, and Scopus), and references list search. Selected articles were categorized based on their type, objective, and main target audience. The methods used in the application studies were extracted and mapped throughout the early stages of development and for their particular aims.
RESULTS: Of 1,961 articles identified, eighty-three studies passed the inclusion criteria, and thirty were included by searching reference lists. There were thirty-one theoretical papers, and eighty-two application papers included. Most studies investigated potential applications/possible improvement of medical devices, developed early assessment framework or included stakeholder perspective in early development stages. Among multiple qualitative and quantitative methods identified, only few were used more than once. The methods aim to inform strategic considerations (e.g., literature review), economic evaluation (e.g., cost-effectiveness analysis), and clinical effectiveness (e.g., clinical trials). Medical devices were often in the prototype product development stage, and the results were usually aimed at informing manufacturers.
CONCLUSIONS: This study showed converging aims yet widely diverging methods for early assessment during medical device development. For early assessment to become an integral part of activities in the development of medical devices, methods need to be clarified and standardized, and the aims and value of assessment itself must be demonstrated to the main stakeholders for assuring effective and efficient medical device development.

Mesh:

Year:  2014        PMID: 24805836     DOI: 10.1017/S0266462314000026

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  14 in total

1.  The role of health technology assessment bodies in shaping drug development.

Authors:  Oriana Ciani; Claudio Jommi
Journal:  Drug Des Devel Ther       Date:  2014-11-10       Impact factor: 4.162

2.  Conceptual model for early health technology assessment of current and novel heart valve interventions.

Authors:  Simone A Huygens; Maureen P M H Rutten-van Mölken; Jos A Bekkers; Ad J J C Bogers; Carlijn V C Bouten; Steven A J Chamuleau; Peter P T de Jaegere; Arie Pieter Kappetein; Jolanda Kluin; Nicolas M D A van Mieghem; Michel I M Versteegh; Maarten Witsenburg; Johanna J M Takkenberg
Journal:  Open Heart       Date:  2016-10-14

3.  Beyond Adoption: A New Framework for Theorizing and Evaluating Nonadoption, Abandonment, and Challenges to the Scale-Up, Spread, and Sustainability of Health and Care Technologies.

Authors:  Trisha Greenhalgh; Joseph Wherton; Chrysanthi Papoutsi; Jennifer Lynch; Gemma Hughes; Christine A'Court; Susan Hinder; Nick Fahy; Rob Procter; Sara Shaw
Journal:  J Med Internet Res       Date:  2017-11-01       Impact factor: 5.428

4.  Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies.

Authors:  Pascale Lehoux; Fiona A Miller; Geneviève Daudelin; Jean-Louis Denis
Journal:  Int J Health Policy Manag       Date:  2017-09-01

5.  The Bright Elusive Butterfly of Value in Health Technology Development Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".

Authors:  Trisha Greenhalgh; Nick Fahy; Sara Shaw
Journal:  Int J Health Policy Manag       Date:  2018-01-01

Review 6.  Biomaterial-driven in situ cardiovascular tissue engineering-a multi-disciplinary perspective.

Authors:  Tamar B Wissing; Valentina Bonito; Carlijn V C Bouten; Anthal I P M Smits
Journal:  NPJ Regen Med       Date:  2017-06-16

7.  The Parker Model: Applying a Qualitative Three-Step Approach to Optimally Utilize Input from Stakeholders When Introducing New Device Technologies in the Management of Chronic Rheumatic Diseases.

Authors:  Tanja S Jørgensen; Marie Skougaard; Peter C Taylor; Hans C Asmussen; Anne Lee; Louise Klokker; Louise Svejstrup; Irina Mountian; Henrik Gudbergsen; Lars Erik Kristensen
Journal:  Patient       Date:  2018-10       Impact factor: 3.883

8.  Early decision-analytic modeling - a case study on vascular closure devices.

Authors:  Alina Brandes; Moritz F Sinner; Stefan Kääb; Wolf H Rogowski
Journal:  BMC Health Serv Res       Date:  2015-10-27       Impact factor: 2.655

Review 9.  Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature.

Authors:  Maarten J IJzerman; Hendrik Koffijberg; Elisabeth Fenwick; Murray Krahn
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

10.  A Web-Based Communication Platform to Improve Home Care Services in Norway (DigiHelse): Pilot Study.

Authors:  Linn Nathalie Støme; Tron Moger; Kristian Kidholm; Kari J Kværner
Journal:  JMIR Form Res       Date:  2020-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.